RxDoctor Payments DataLook up a doctor →

Daniel Kohane, MD

Interventional Pain Medicine · Babylon, NYNPI 1235399734

Payments from drug & device makers

$26,629in general payments, 2019–2025

Across 1,303 payments — averaging $20.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • International Rehabilitative Sciences, Inc$7K
  • Collegium Pharmaceutical, Inc.$2K
  • Boston Scientific$2K
  • Abbott$2K
  • AbbVie$1K
  • Medtronic$952
  • plus $11K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
International Rehabilitative Sciences, Inc1$7,164
Collegium Pharmaceutical, Inc.392$2,299
Boston Scientific126$2,298
Abbott101$1,741
AbbVie(2 entities)59$1,093
Medtronic(2 entities)58$952
Relievant Medsystems, Inc.22$907
Nevro Corp.78$897
Scilex Pharmaceuticals Inc.40$756
Forte Bio-pharma LLC18$727
Biodelivery Sciences International, Inc.75$608
Amgen(2 entities)29$468
Vertex17$457
Saluda Medical Americas, Inc.5$456
Averitas Pharma Inc.23$441
Vertos Medical, Inc.15$404
Si-bone, Inc.8$402
Nalu Medical, Inc.9$366
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC21$330
Pfizer15$309
Azurity Pharmaceuticals, Inc.19$306
Zyla Life Sciences, Inc.22$294
Virtus Pharmaceuticals LLC21$280
Protega Pharmaceutials Inc10$185
Arbor Pharmaceuticals, Inc.10$181
Fidia Pharma USA Inc.10$154
Novartis7$141
IBSA Pharma Inc.7$139
Kowa Pharmaceuticals America, Inc.9$139
Biohaven Pharmaceuticals, Inc.5$126
Redhill Biopharma Inc.6$121
MML US, Inc.2$118
DJO, LLC2$114
Biotronik NRO, Inc.3$101
Biohaven Pharmaceutical Holding Company Ltd.4$96
Lundbeck LLC5$95
Johnson & Johnson4$85
Daiichi Sankyo Inc.5$84
Assertio Therapeutics, Inc.4$61
Bioventus LLC3$61
Axsome Therapeutics, Inc.2$51
GRT US Holding, Inc.2$51
Takeda Pharmaceuticals U.S.A., Inc.3$51
Stimwave Technologies Incorporated1$50
Valinor Pharma, LLC3$47
Curonix LLC1$46
MDD US Operations, LLC2$46
Sentynl Therapeutics, Inc.3$41
AstraZeneca2$40
Almatica Pharma LLC2$38
Inspire Medical Systems, Inc.2$37
USWM, LLC2$27
Ferring Pharmaceuticals Inc.1$25
Zimmer Biomet1$24
Baudax Bio Inc.1$19
Stryker1$18
Shionogi Inc1$17
Tonix Medicines, Inc.1$16
Sanofi-aventis U.S. LLC1$15
Acelrx Pharmaceuticals, Inc.1$12

How this compares

$26,629 in reported general payments places this provider in the 85th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York →

Medicare billing

Part B allowed, 2024
$412,982
Medicare patients
380
Services billed
6,202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Babylon

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →